VagiClear Duo is the newest product in Key Pharmaceuticals’ Vagi range for vaginal symptoms. A recent survey found that more than 46% of women have misdiagnosed themselves with thrush and bought the wrong product. Vaginal pH can be detected with the use of VagiTest to determine the best method to combat the symptoms. VagiClear Duo is recommended for normal vaginal pH and contains a single dose oral capsule as well as an antifungal cream for the relief of external symptoms.
RRP: $9.90 (VagiTest); $24.95 (VagiCare), $24.95 (VagiClear) Stockist: 1800 653 373The above article was sent to subscribers in Pharmacy Daily's issue from 24 Aug 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Aug 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.